UB Paderborn / Katalog / Suche / in CDI

Management of Antiplatelet Therapy During Left Ventricular Assist Device Support After Thrombo-Hemorrhagic Events

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S250-S250

2017

Link zum Volltext

Verfügbarkeit prüfen

Is Bridging Anticoagulation Required in LVAD Patients with Subtherapeutic INR?

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S246-S246

2017

Link zum Volltext

Verfügbarkeit prüfen

Pre-Implant Digoxin Utilization and Impact on Survival in Left Ventricular Assist Device Recipients

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S445-S445

2017

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Patient Blood Pressure on the Occurrence of Serious Adverse Events in the ENDURANCE Trial

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S193-S194

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy

Circulation (New York, N.Y.), 2004-05, Vol.109 (19), p.2263-2265

2004

Link zum Volltext

Verfügbarkeit prüfen

Donor Under Sizing Results in Worse Post-Transplant Survival in LVAD Patients: A UNOS Database Analysis

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S17-S18

2015

Link zum Volltext

Verfügbarkeit prüfen

Explantation of Left Ventricular Assist Devices After Myocardial Recovery: A Single Center Study

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S41-S41

2015

Link zum Volltext

Verfügbarkeit prüfen

The Use of Integrilin Alone or in Combination with Heparin or Argatroban for Suspected Pump Thrombosis in Patients with Left Ventricular Assist Devices

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S252-S253

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S24-S25

2016

Link zum Volltext

Verfügbarkeit prüfen

The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S10-S10

2017

Link zum Volltext

Verfügbarkeit prüfen

Remission From Stage D Heart Failure (RESTAGE-HF): Early Results From a Prospective Multi-Center Study of Myocardial Recovery

The Journal of heart and lung transplantation, , Vol.34 (4), p.S40-S41

Link zum Volltext

Verfügbarkeit prüfen

Psychosocial Factors Do Not Influence Survival or the Development of Complications After Left Ventricular Assist Device Implantation

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S89-S89

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of Prior Implantation of HeartMate II Left Ventricular Assistive Device with Post-Heart Transplant Mortality

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S32-S32

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Total Artificial Heart and Biventricular Assist Device Support as Bridge-to-Transplantation

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S36-S36

2014

Link zum Volltext

Verfügbarkeit prüfen

An Analysis of Early Versus Late Right Heart Failure With an Intrapericardial Continuous Flow LVAD

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S113-S114

2015

Link zum Volltext

Verfügbarkeit prüfen

HeartWare HVAD for the Treatment of Patients With Advanced Heart Failure Ineligible for Cardiac Transplantation: Results of the ENDURANCE Destination Therapy Trial

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S9-S9

2015

Link zum Volltext

Verfügbarkeit prüfen

Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery

The Journal of thoracic and cardiovascular surgery, 2008-02, Vol.135 (2), p.453-454

2008

Link zum Volltext

Verfügbarkeit prüfen

Does Educational Level and Insurance Impact Mid-Term Survival after Left Ventricular Assist Device Implantation?

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S124-S125

2013

Link zum Volltext

Verfügbarkeit prüfen

258 Panel Reactive Antibody in Bridge to Transplant Left Ventricular Assist Device Patients: Impact on Patient Survival after Cardiac Transplant

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S93-S93

2012

Link zum Volltext

Verfügbarkeit prüfen

564 Use of Novel Thrombosis Index of Risk (TIR) as Indicator for Left Ventricular Assist Device (LVAD) Thrombosis

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S196-S196

2012

Link zum Volltext

Verfügbarkeit prüfen

Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S10-S10

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of Device Design and Patient Management on the Incidence of Neurologic Events after HVAD Left Ventricular Assist Device

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S10-S10

2014

Link zum Volltext

Verfügbarkeit prüfen

638 Correlation of Pre-Implant Norepinephrine Transporter Levels with Myocardial Recovery during Left Ventricular Assist Device Support

The Journal of heart and lung transplantation, 2011, Vol.30 (4), p.S212-S213

2011

Link zum Volltext

Verfügbarkeit prüfen

1 Initial Results of the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S10-S10

2012

Link zum Volltext

Verfügbarkeit prüfen

184: Myocardial Recovery Is Associated with Low Levels of Circulating MMP8 at LVAD Implantation

The Journal of heart and lung transplantation, 2010-02, Vol.29 (2), p.S65-S66

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Management of Antiplatelet Therapy During Left Ventricular Assist Device Support After Thrombo-Hemorrhagic Events

Is Bridging Anticoagulation Required in LVAD Patients with Subtherapeutic INR?

Pre-Implant Digoxin Utilization and Impact on Survival in Left Ventricular Assist Device Recipients

The Effects of Patient Blood Pressure on the Occurrence of Serious Adverse Events in the ENDURANCE Trial

Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy

Donor Under Sizing Results in Worse Post-Transplant Survival in LVAD Patients: A UNOS Database Analysis

Explantation of Left Ventricular Assist Devices After Myocardial Recovery: A Single Center Study

The Use of Integrilin Alone or in Combination with Heparin or Argatroban for Suspected Pump Thrombosis in Patients with Left Ventricular Assist Devices

Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial

The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial

Remission From Stage D Heart Failure (RESTAGE-HF): Early Results From a Prospective Multi-Center Study of Myocardial Recovery

Psychosocial Factors Do Not Influence Survival or the Development of Complications After Left Ventricular Assist Device Implantation

Association of Prior Implantation of HeartMate II Left Ventricular Assistive Device with Post-Heart Transplant Mortality

Comparison of Total Artificial Heart and Biventricular Assist Device Support as Bridge-to-Transplantation

An Analysis of Early Versus Late Right Heart Failure With an Intrapericardial Continuous Flow LVAD

HeartWare HVAD for the Treatment of Patients With Advanced Heart Failure Ineligible for Cardiac Transplantation: Results of the ENDURANCE Destination Therapy Trial

Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery

Does Educational Level and Insurance Impact Mid-Term Survival after Left Ventricular Assist Device Implantation?

258 Panel Reactive Antibody in Bridge to Transplant Left Ventricular Assist Device Patients: Impact on Patient Survival after Cardiac Transplant

564 Use of Novel Thrombosis Index of Risk (TIR) as Indicator for Left Ventricular Assist Device (LVAD) Thrombosis

Two-Year Outcomes in the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry

Impact of Device Design and Patient Management on the Incidence of Neurologic Events after HVAD Left Ventricular Assist Device

638 Correlation of Pre-Implant Norepinephrine Transporter Levels with Myocardial Recovery during Left Ventricular Assist Device Support

1 Initial Results of the Destination Therapy Post-FDA-Approval Study with a Continuous Flow Left Ventricular Assist Device: A Prospective Study Using the INTERMACS Registry

184: Myocardial Recovery Is Associated with Low Levels of Circulating MMP8 at LVAD Implantation

Suchergebnisse filtern